Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Problems in Hodgkin's disease management.

× No keyword cloud information.

15 in total

Review 1. Early-stage Hodgkin's disease.

Authors: A Josting; V Diehl
Journal: Curr Oncol Rep Date: 2001-05 Impact factor: 5.075

2. Treatment of refractory Hodgkin's disease with modified Stanford V program.

Authors: A Avilés; N Neri; E L García; A Talavera; J C Díaz-Maqueo
Journal: Med Oncol Date: 2001 Impact factor: 3.064

Review 3. Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database.

Authors: Kevin D Hill; Heather T Henderson; Christoph P Hornik; Jennifer S Li
Journal: Cardiol Young Date: 2015-08 Impact factor: 1.093

Review 4. Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients.

Authors: Karoline Spaepen; Sigrid Stroobants; Gregor Verhoef; Luc Mortelmans
Journal: Eur J Nucl Med Mol Imaging Date: 2003-04-23 Impact factor: 9.236

5. CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma.

Authors: J Walewski; J B Krzyzanowska; E Kraszewska; E Lampka; J Romejko-Jarosińska; Z Miśkiewicz; J Meder
Journal: Med Oncol Date: 2000-08 Impact factor: 3.064

Review 6. Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.

Authors: David Barrett; Jonathan D Fish; Stephan A Grupp
Journal: Pediatr Clin North Am Date: 2010-02 Impact factor: 3.278

7. Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma.

Authors: Ying-Jie Zhu; Yue-Li Sun; Yi Xia; Wen-Qi Jiang; Jia-Jia Huang; Hui-Qiang Huang; Tong-Yu Lin; Zhong-Zhen Guan; Zhi-Ming Li
Journal: Med Oncol Date: 2011-03-10 Impact factor: 3.064

Review 8. Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.

Authors: Run Yang; Changming Tan; Masoud Najafi
Journal: Inflammopharmacology Date: 2021-11-23 Impact factor: 4.473

Review 9. PET and restaging of malignant lymphoma including residual masses and relapse.

Authors: S N Reske
Journal: Eur J Nucl Med Mol Imaging Date: 2003-05-14 Impact factor: 9.236

10. Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.

Authors: Marcel P Devetten; Parameswaran N Hari; Jeanette Carreras; Brent R Logan; Koen van Besien; Christopher N Bredeson; César O Freytes; Robert Peter Gale; John Gibson; Sergio A Giralt; Steven C Goldstein; Vikas Gupta; David I Marks; Richard T Maziarz; Julie M Vose; Hillard M Lazarus; Paolo Anderlini
Journal: Biol Blood Marrow Transplant Date: 2009-01 Impact factor: 5.742